期刊文献+

原发性高血压伴阻塞性睡眠呼吸暂停低通气综合征对左心室结构的影响 被引量:15

The Impact of Essential Hypertension with Obstructive Sleep Apnea-Hypopnea Syndrome on Left Ventricular Configuration
原文传递
导出
摘要 目的研究原发性高血压(EH)伴阻塞性睡眠呼吸暂停低通气综合征(OSAHS)与左心室结构改变的关系并分析其影响因素。方法对2004-07-2007-07住院的EH患者进行睡眠监测,并对其一般资料、生化指标、超声心动图检查结果进行分析,比较EH+OSAHS与EH患者间左心室构型的差异,观察其影响因素。结果EH+OSAHS组年龄、男性比例、体质量指数、收缩压、空腹及餐后2 h血糖均高于EH组(均P<0.01);EH+OSAHS组的左室舒张期内径、室间隔厚度、左室后壁厚度、左室质量指数、相对室壁厚度均高于EH组(均P<0.01);与左心室肥厚发生相关的危险因素为OSAHS、高血压病程、血压分级、糖尿病、肾功能不全。结论与EH相比,EH+OSAHS左心室构型改变更严重。 Objective To examine whether obstructive sleep apnea-hypopnea syndrome(OSAHS) is associated with left ventricular structural abnormalities in hypertensive patients.Methods Portable polysomnography,echocardiography and laboratory testing were performed in 569 consecutive subjects from the department of hypertension,Ruijin Hospital from July,2004 to July,2007.Difference of left ventricular structure was compared between patients with and without OSAHS.Results The age,proportion of gender,body mass index,systolic blood pressure,the levels of fasting blood glucose and 2 h postprandial blood glucose were significantly higher in subjects with OSAHS compared with those without OSAHS(P〈0.01).LVDd,LVST,PWT,LVMI and RWT were significantly greater in those with OSAHS than in those without OSAHS(P〈0.01).The risk factors of left ventricular hypertrophy were OSAHS,the duration and the level of hypertension,diabetes and renal impairment.Conclusion Hypertensive patients with OSAHS have more prominent ventricular hypertrophy compared with those without OSAHS.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2010年第4期349-352,共4页 Chinese Journal of Hypertension
基金 上海市卫生局基金(054043)上海市教委基金(05BZ09) "十一五"国家科技支撑计划项目(2006BAI01A03)子课题
关键词 原发性高血压 阻塞性睡眠呼吸暂停低通气综合征 左心室构型 危险因素 Essential hypertension Obstructive sleep apnea-hypopnea syndrome Left ventricular configuration Risk factor
  • 相关文献

参考文献23

  • 1Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of eehocardiographieally determined left ventrieular mass in the Framingham Heart Study[J]. N Engl J Med, 1990,322 (22): 1561- 1566.
  • 2Chami HA, Devereux RB, Gottdiener JS, et al. Left ventrieular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study[J]. Circulation, 2008, 117 (20): 2599-2607.
  • 3Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension [J]. N Engl J Med,2000,342(19): 1378-1384.
  • 4ESH/ESC Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension[J], J Hypertens, 2003,21 (16) 1011-1053.
  • 5Ganau A, Devereux RB, Roman MJ, etal. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension[J]. J Am Coll Carddiol, 1992,19 (7) : 1550-1558.
  • 6National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification[J]. Am J kidney dis,2008,51(2) :346.
  • 7World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications[R]. WHO/NCD/NCS, 1999 : 31-32.
  • 8Frohlieh ED. Risk mechanisms in hypertensive heart disease[J]. Hypertension, 1999,34(4): 782-789.
  • 9Kazzam E, Ghurbana BA, Obineche EN, et al. Hypertenzion still an important cause of heart failure[J]. J Hum Hypertens, 2005,19(4): 267-275.
  • 10Agabiti-Rosei E, Muiesan ML, Salvetti M. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy[J]. J Am Soc Nephrol,2006,17(4 Suppl 2):S104-108.

二级参考文献13

  • 1慈书平,李晖,宋红,江时森,李俭春,潘昌华.睡眠呼吸暂停对血压昼夜节律和内皮素的影响[J].中华结核和呼吸杂志,1996,19(4):223-231. 被引量:22
  • 2Good friend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea and Aldosterone:theory and therapy[J]. Hypertension, 2004,43: 518-524.
  • 3Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea:implications for cardiac and vascular disease[J]. JAMA,2003,290:1906-1914.
  • 4Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea[J]. Acta Physiol Scand, 2003, 177 : 385-390.
  • 5Ziegler MG. Sleep disorders and the failure to lower nocturnal blood pressure[J]. Curr Opin Nephrol Hypertens, 2003,12:97-102.
  • 6Peter JH, Grote L, Fus E, et al. REM-sleep-hypetension in obstructive sleep apnoea[J]. Eur J Med Res, 1995,18 : 132-136.
  • 7Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea:response to CPAP therapy[J]. Thorax,2000,55 : 1046-1051.
  • 8Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure[J]. J Hypertens, 1999,17 : 61-66.
  • 9Goodfriend TL, Calhoun DA. Resistant hypertenion, obesity sleep apnea and aldosterone:theory and therapy[J]. Hypertension, 2004,43 : 518-524.
  • 10Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia:the renin-angiotension system[J]. J Apple Physiol, 2002,92 : 627-633.

共引文献13

同被引文献150

引证文献15

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部